Table 1 Clinico-pathological features of the patient cohort
Characteristic | Categories | No. of patients (%) |
|---|---|---|
n = 29 | ||
Age | <45 | 12 (41.4) |
>45 | 17 (58.6) | |
Grade (pre-NAC) | 2 | 9 (31) |
3 | 20 (69) | |
Stage (pre-NAC) | T2 | 19 (65.5) |
T3 | 10 (34.5) | |
MRI response | Minimal | 9 (31) |
Partial | 20 (69) | |
NAC regimen | Epirubicin + cyclophosphamide (EC) | 5 (17.2) |
EC + taxanes | 24 (82.8) | |
Lymphovascular invasion | Positive | 11 (37.9) |
Axillary metastasis | Positive | 15 (51.7) |
Oestrogen receptor | Positive | 17 (58.6) |
Her2 | Positive | 3 (10.3) |
Surgery | Breast conserving | 11 (37.9Â %) |
Mastectomy | 18 (62.1Â %) |